NCT00161759已完成1 期
A Study to Assess the Safety and Efficacy of Fibrin Sealant (FS 4IU) for Wound Healing in Subjects With Burn Wounds Requiring Skin Grafting Procedures
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 24
研究概览
简要总结
The purpose of this study is to assess if Fibrin Sealant 4IU is as safe and efficacious as staples (the current standard of care) to achieve fixation of skin grafts and wound healing in subjects with burn wounds. Each subject receives staples as well as FS 4IU on comparable treatment sites.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 6 Years 至 65 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent obtained from either the subject or the subject's legally acceptable representative prior to screening activities
- •Male or female age >= 6 and <= 65 years of age
- •Total burn wounds measuring <= 40% TBSA to include a deep partial thickness/full thickness area requiring autologous split thickness sheet skin grafts
- •The selected test area consisting of a contiguous, deep partial thickness/full thickness burn wound between 2% and 8% TBSA, which can be divided into two approximate halves or two bilateral wounds (each measuring between 1% and 4% TBSA)
- •Females of child-bearing potential with a negative urine or serum pregnancy test on admission
- •Able and willing to comply with the procedures required by the protocol
排除标准
- •Conductive electrical burns and chemical burns
- •Digits, head, genitalia, palms of hands, soles of feet, and face are excluded as test sites
- •Circumferential burns are excluded as a test area
- •4th or 5th degree burns
- •Test area with infection as determined clinically by the Investigator prior to surgery
- •Venous or arterial vascular disorder directly affecting a designated test area
- •Known immune deficiency disorder, either congenital or acquired
- •Chronically malnourished as determined clinically by the investigator prior to surgery (Investigators are responsible for determining subjects are chronically malnourished during the screening process. Investigators should take into consideration the following parameters: Medical history and physical appearance, the subject's body mass index, and any significant laboratory findings)
- •Severe respiratory problems or concurrent head trauma at hospital admission
- •Any chronic condition requiring the use of systemic corticosteroids 30 days prior to study entry and anytime during the course of the study
- •Known or newly diagnosed diabetics requiring insulin
- •Any other acute or chronic concurrent medical condition(s) that in the Investigator's opinion are a contraindication to skin grafting and study participation
- •Known or suspected hypersensitivity to bovine protein
- •Concurrent participation in another clinical trial in which an investigational agent is used. (Subjects must not have been enrolled in another clinical trial within 30 days of enrolling in this trial).
研究者
研究点 (24)
Loading locations...
相似试验
已完成
2 期
Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift ProceduresFacial Rhytidectomy (Face-lift)NCT00708071Baxter Healthcare Corporation45
已完成
2 期
Fibrin Sealant Vascular Surgery StudyAdjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)NCT00576420Baxter Healthcare Corporation101
进行中（未招募）
3 期
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)Esophageal Anastomotic LeakNCT03847857Sun Yat-sen University360
已完成
3 期
The Fibrin Pad Liver StudyHemorrhageNCT01166243Ethicon, Inc.84
Unknown
不适用
Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic BrowliftCompare Ecchymosis and Edema for Fibrin Sealant and no Fibrin SealantNCT01320514Nguyen, Davis B., M.D.10